Pipeline

Apricus Pipeline Chart

Phase 1
Phase 2
Phase 3
Approved
Marketed

Vitaros®/™

Erectile Dysfunction
Marketed in Europe | Approved in Canada | Development Stage in the U.S.

RayVa

Raynaud’s Phenomenon

Vitaros®

It is estimated that, worldwide, 150 million men suffer with erectile dysfunction. Factors contributing to the appearance of the disease or its severity include medical history, tobacco use and age. Erectile dysfunction is also found in men with cardiovascular disease.

> Click to Read More

RayVa™

Raynaud’s phenomenon (RP) is fairly common with a reported prevalence up to 5% with a disproportionately higher number of women affected. Triggers for an Raynaud’s phenomenon attack include cold temperatures, caffeine, smoking or emotional stress. Attacks are the result of reduced blood flow to areas including fingers, toes, nose and ears.

> Click to Read More